ROCO
8935
Market cap67mUSD
Oct 08, Last price
18.90TWD
1D
3.28%
1Q
-16.56%
Jan 2017
252.61%
IPO
-0.37%
Name
Pontex Polyblend Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Pontex Polyblend Co., Ltd., established in 1982 and headquartered in Taichung City, Taiwan, is a global enterprise specializing in two core areas: the production of engineering plastics compound materials and footwear manufacturing through injection molding. The company's operations span Taiwan, mainland China, the United States, and various international markets. Pontex Polyblend offers a wide array of plastic compound materials, including ABS, PC, nylon, PP, PBT, NPE, TPU, PLA, PBS, and r-PET. These advanced materials find diverse applications in sectors such as consumer electronics (3C), industrial machinery parts, automotive and motorcycle components, household consumer goods, sporting equipment and toys, and medical supplies. In its footwear division, the company manufactures various sports equipment components, such as outsoles for baseball, football, soccer, and bicycles. It also produces critical shoe components like midsoles, shanks, and counters, alongside complete sports footwear. Furthermore, Pontex Polyblend acts as an original equipment manufacturer (OEM), producing injection-molded women's shoe uppers for the well-known CROCS brand.
Key people
Zongxian Liao
Deputy General Manager · since 2008
Jingcheng Hong
Corporate Governance Officer · since 2023
Youfa Yu
General Manager-General Management Department · since 2012
Jinghui Zhu
Head of Finance and Accounting · since 2012
Guozhu Chen
Director · since 2004
Zongyi Chen
Director · since 2022
Director · since 2025
Pin-Zhi Huang
Director · since 2025
Qi-Wen Huang
Director · since 2023
Xingyi Lai
Director · since 2025
Jihuan Li
Director · since 2025
Guo-Rong Shen
Chairman of the Board, General Manager · since 2025
Mao-Ken Shen
General Manager, Director · since 2025
Dijun Xiong
Director · since 2014
Wenzong Xu
Director · since 2010
Mingtong Zhang
Director · since 2022
Rongzhu Zheng
Director · since 2022
Ming-Cheng Cheng
Independent Director · since 2025
Renjie Hong
Independent Director · since 2025
Wenbin Li
Independent Director · since 2022
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||